At Rush University Medical Center, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

Oxytocin and Social Thinking Groups for Autism Spectrum Disorder

Clinical Trial Title: 
Oxytocin and social thinking groups for autism spectrum disorder.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Latha Soorya, PhD
Clinical Trial Protocol Description: 

The Autism Assessment, Research, Treatment, and Services Center at Rush University Medical Center is conducting a unique study of oxytocin and social skills groups. Oxytocin is a hormone that plays an important role in social bonding and connections. In this study, participants will take oxytocin a few times a week when working on social thinking skills. We are examining the effects of this novel combination therapy on social thinking skills, such as emotion recognition and perspective taking. Children will be randomly assigned to either the oxytocin + social thinking group or a facilitated play group.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are between the ages of 8 and 11 years old and have a parent/caregiver.
  • Have a diagnosis of autism spectrum disorder.
  • Speak and understand English.
  • Talk in full sentences.

This is a partial list of eligibility requirements. 

Clinical Trial Area: 
Autism Spectrum Disorders
Contact Email: 
Contact Phone: 
(312) 942-6331
Contact Name: 
Sarely Licona